Trials / Terminated
TerminatedNCT01039038
Feasibility Study of a Dose Increase by a Boost of Curietherapy in Pulse Dose Rate (PDR) Associated With the Extern Radiotherapy in Prostate Cancer
A Phase II Study Evaluating the Feasibility of a Dose Increase by a Boost of Curietherapy in PDR Associated With the Extern Radiotherapy in Intermediate Risk in the Prostate Cancer
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Centre Francois Baclesse · Academic / Other
- Sex
- Male
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the trial is to evaluating the feasibility of dose increase by a boost of curietherapy in PDR (at least 40 Gy on D95) associated to extern radiotherapy (34 Gy) in intermediate risk in prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | curietherapy and radiotherapy | boost of curietherapy(40 Gy)and external radiotherapy (34 Gy) |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2009-12-24
- Last updated
- 2011-11-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01039038. Inclusion in this directory is not an endorsement.